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Abstract
We consider estimation of an optimal individualized treatment rule from observa-
tional and randomized studies when a high-dimensional vector of baseline variables
is available. Our optimality criterion is with respect to delaying expected time to
occurrence of an event of interest (e.g., death or relapse of cancer). We leverage semi-
parametric efficiency theory to construct estimators with desirable properties such as
double robustness. We propose two estimators of the optimal rule, which arise from
considering two loss functions aimed at (i) directly estimating the conditional treatment
effect (also know as the blip function), and (ii) recasting the problem as a weighted
classification problem that uses the 0-1 loss function. Our estimated rules are super
learning ensembles that minimize the cross-validated risk of a linear combination in a
user-supplied library of candidate estimators. We prove oracle inequalities bounding
the finite sample excess risk of the estimator. The bounds depend on the excess risk
of the oracle selector and a doubly robust term related to estimation of the nuisance
parameters. We discuss some important implications of these oracle inequalities such
as the convergence rates of the value of our estimator to that of the oracle selector.
We illustrate our methods in the analysis of a phase III randomized study testing the
efficacy of a new therapy for the treatment of breast cancer.
1 Introduction
Individualized treatment rules play a fundamental role in the precision medicine model for
healthcare, whereby medical decisions are targeted to the individual based on their expected
clinical response, instead of the traditional one-size-fits-all approach. Mathematically, a
treatment rule is a function that maps an individual’s pre-treatment covariates into an
∗corresponding author: ild2005@med.cornell.edu
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optimal treatment choice. In this paper, we are concerned with learning the optimal rules
from data collected as part of an observational or randomized study, where optimality is
defined as the maximum delay in the expected time of occurrence of an undesirable event
(e.g., death or relapse).
Recent advances in biomedical imaging and gene expression technology produce large
amounts of data that can be used to tailor treatment to very specific patient characteristics.
Methods to estimate the optimal rule when it is defined with respect to a single time-
point outcome include the work of Qian and Murphy (2011); Zhao et al. (2012); Song
et al. (2015); Rubin et al. (2012); McKeague and Qian (2014), among others. Methods
to solve the problem using survival outcomes subject to informative censoring have been
proposed by Zhao et al. (2011); Goldberg and Kosorok (2012). The latter methods use Q-
learning, relying on sequential support vector regressions, to estimate the optimal sequential
treatment rule that optimizes a survival outcome under right-censoring. Geng et al. (2015)
also tackle estimation of the optimal rule in a survival setting using `1 regularization for the
outcome regression under the strong assumption that censoring is independent of covariates
and the outcome, but their decision functions are restricted to linear functions. Zhao et al.
(2015) generalize the weighted classification approach of Zhao et al. (2012) to allow for
informative censoring and doubly robust loss functions, but their decision functions are
restricted to support vector machines. Bai et al. (2016) present methods for estimating
optimal rules with a survival outcome subject to informative censoring. They consider two
strategies based on estimation of the blip function and based on a classification perspective.
Their methods are restricted to decision functions that can be indexed by a Euclidean
vector and parametric nuisance estimators, and are therefore of limited applicability to
high-dimensional data. All the above methods are potential candidates in the library of
estimators that constitute our ensembles.
In this article, we propose two methods to construct an ensemble of decision functions
for the optimal rule. Our ensembles are linear combinations of estimators in a user-supplied
library, where the coefficients in the linear combination are chosen to minimize the cross-
validated risk. We propose to use a doubly robust loss function with roots in efficient
estimation theory for marginal causal effects (Moore and van der Laan, 2009; Dı´az et al.,
2015). In our context, double robustness means that the estimated rules will have certain
optimality properties under consistent estimation of at least one of two nuisance param-
eters: (a) the hazard of the outcome at each time point conditional on covariates and
treatment, and (b) the hazard of censoring and the treatment mechanism.
The library of candidate estimators may contain any of the algorithms discussed in
the previous paragraphs. In light of the no free lunch theorems of Wolpert (2002) for
supervised learning, for any given dataset, our ensembles are expected to have better or
equal generalization error than any of the individual candidates in the library. We provide a
formal proof of this claim in the form of an oracle inequality, which bounds the excess risk of
our estimator in terms of the excess risk of the oracle estimator, defined as the combination
of estimators that would be chosen in a hypothetical world in which an infinite validation
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sample is available and at least one of the nuisance parameters is known. Our methods
are developed under the assumption that censoring is at random (Rubin, 1987), which
means that censoring is random within strata of treatment and baseline variables. We also
assume that treatment is randomized within strata of the covariates, either by nature or
by experimentation.
The finite sample bounds we present are inspired by developments in the targeted
learning literature, which establish the optimality of cross-validation in estimator selection
for high-dimensional parameters (van der Laan and Dudoit, 2003). Related to our work,
Luedtke and van der Laan (2016) consider super learning ensembles for estimation of
optimal DTRs in two time points. They present oracle inequalities for super learning
of the optimal rule using a loss function indexed by the treatment mechanism, which is
assumed known. We generalize their results in the following ways: (i) we provide oracle
inequalities under a doubly robust loss function indexed by two nuisance parameters, when
neither of the nuisance parameters is known, (ii) we show that the oracle inequalities inherit
the double robustness property of the loss function, and (iii) we present comparable oracle
inequalities for the 0-1 loss function. In addition, we discuss how these oracle inequalities
are related to the convergence of the value of the rule under a margin assumption describing
the behavior of the blip function in the boundary of the decision threshold.
2 Data and Notation
Assume individuals are monitored at K time points t = {1, . . . ,K}. Let T denote a time-
to-event outcome taking values in {1, . . . ,K} ∪ {∞}, where T = ∞ represents no event
occurring in the follow-up period. Let C ∈ {0, . . . ,K} denote the censoring time defined
as the time at which the individual is last observed in the study, and let C = K, represent
administrative censoring. Let A ∈ {0, 1} denote study arm assignment, and let W denote
a vector of baseline variables, which may include gene expression as well as demographic,
comorbidity, and other clinical data. Denote 1(·) the indicator variable taking value 1 if
the argument is true and 0 otherwise. The observed data vector for each participant is
O = (W,A,∆, T˜ ), where T˜ = min(C, T ), and ∆ = 1{T ≤ C} is the indicator that the
participant’s event time is observed (uncensored). For a random variable X, we let X take
values on a set O.
We assume the observed data vector for each participant i, denotedOi = (Wi, Ai,∆i, T˜i),
is an independent, identically distributed draw from the unknown joint distribution P0 on
(W,A,∆, T˜ ). The empirical distribution of O1, . . . , On is denoted with Pn. We assume
P0 ∈ M, where M is the nonparametric model defined as all continuous densities on O
with respect to a dominating measure ν. We use P to denote a generic distribution P ∈M,
and E0(·) to denote expectation with respect to P0, and E(·) is used to denote expecta-
tion over draws of O1, . . . , On. For a function f(o), we denote Pf =
∫
f(o)dP (o), and
||f ||2 = P0f2. We use a . b to denote that a is smaller or equal than b up to a universal
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constant.
We can equivalently encode a single participant’s data vector O using the following
longitudinal data structure:
O = (W,A,R0, L1, R1, L2 . . . , RK−1, LK), (1)
where Rt = 1{T˜ = t,∆ = 0} and Lt = 1{T˜ = t,∆ = 1}, for t ∈ {0, . . . ,K}. For a random
variable X, we denote its history through time t as X¯t = (X0, . . . , Xt). For a given scalar
x, the expression X¯t = x denotes element-wise equality.
Define the following indicator variables for each t ≥ 1: It = 1{R¯t−1 = 0, L¯t−1 = 0},
Jt = 1{R¯t−1 = 0, L¯t = 0}. The variable It is the indicator based on the data through time
t− 1 that a participant is at risk of the event being observed at time t. Analogously, Jt is
the indicator based on the outcome data through time t and censoring data before time t
that a participant is at risk of censoring at time t. We define J0 = 1.
Define the discrete hazard function for survival at time m ∈ {1, . . . ,K}:
h(m, a,w) = P0(Lm = 1 | Im = 1, A = a,W = w),
among the population at risk at time m within strata of study arm and baseline variables.
Similarly, for the censoring variable C, define the censoring hazard at time m ∈ {0, . . . ,K}:
gR(m, a,w) = P0(Rm = 1 | Jm = 1, A = a,W = w).
We use the notation gA(a,w) = P0(A = a |W = w), g = (gA, gR), and η = (h, gA, gR). Let
pW denote the marginal distribution of the baseline variables W . We add the subscript 0
to pW , g, h to denote the corresponding quantities under P0.
3 Treatment Effect, Identification, and Optimal Individual-
ized Treatment Rules
3.1 Potential Outcomes and Causal Parameter
Define the potential outcomes Ta : a ∈ {0, 1} as the event times that would have been
observed had study arm assignment A = a and censoring time C = K been externally
set with probability one. For a restriction time τ ∈ {1, . . . ,K} of interest, we define the
restricted survival time under treatment arm A = a as min(Ta, τ). For a transformation
Z of W , the treatment effect within strata of the covariates Z may be defined in terms of
the so-called full-data blip function (see e.g., Robins, 1997) of the restricted mean survival
time:
θc(z) = E{min(T1, τ)−min(T0, τ) | Z = z}.
The transformation Z may represent a subset of covariates (e.g., gene expression), or
the whole vector W . We define the marginal treatment effect as θc,m = E{min(T1, τ) −
min(T0, τ)}.
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The subscript c denotes a causal parameter, that is, a parameter of the distribu-
tion of the potential outcomes T1 and T0. It can be shown (see Dı´az et al., 2015) that
E{min(Ta, τ) | Z = z} =
∑τ−1
t=0 Sc(t, a, z), where Sc(t, a, z) = P (Ta > t | Z = z) is the sur-
vival probability corresponding to the potential outcome under assignment to arm A = a
within strata Z = z. As a result, θc(z) may be expressed as
θc(z) =
τ−1∑
t=1
{Sc(t, 1, z)− Sc(t, 0, z)}, (2)
since Sc(0, a, z) = 1 for a ∈ {0, 1} and for all z.
An individualized treatment rule d is a function that maps the covariate values z of
a given participant to a personalized treatment decision in {0, 1}. The potential time to
event under a rule d is defined as Td = d(z)T1 + {1− d(z)}T0. Accordingly, the restricted
mean survival time under a treatment rule that assigns treatment according to d(z) is equal
to
E{min(Td, τ)} = E{d(Z)[min(T1, τ)−min(T0, τ)]}+ E{min(T0, τ)}.
Because the last term does not depend on d(z), we define the value of the rule d as
Vc(d) = E{d(Z)[min(T1, τ)−min(T0, τ)]} = E{d(Z)θc(Z)}.
The above equation provides the basis for the definition of an optimal rule as
dc(z) = arg max
d∈D
Vc(d) = 1{θc(z) > 0},
where D = {d : Z → {0, 1}} is the space of functions that map the range of Z into a
treatment decision in {0, 1}. We define optimality of an rule with respect to the restricted
mean survival time, though other effect measures could also be used.
3.2 Identification of Parameters in Terms of Observed Data Generating
Distribution P0
In this section we show how the blip function θc(z), the value function Vc(d), and the
optimal rule dc(z), which are defined above in terms of the distribution of potential out-
comes, can be equivalently expressed as functions θ0(z), V0(d), and d0(z) of the observed
data distribution P0(W,A,∆, T˜ ), under the assumptions C.1-C.4 below. This is useful
since the potential outcomes are not always observed, in contrast to the observed data
vector (W,A,∆, T˜ ) for each participant, whose distribution we can make direct statistical
inferences about.
Define the following assumptions:
C.1 (Consistency). T = 1(A = 0)T0 + 1(A = 1)T1
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C.2 (Randomization). A is independent of Ta conditional on W , for each a ∈ {0, 1}
C.3 (Random censoring). C is independent of Ta conditional on (A,W ), for each a ∈ {0, 1}
C.4 (Strong positivity). P0(gA,0(a,W ) > ) = 1 and P0(gR,0(t, a,W ) < 1− ) = 1 for each
a ∈ {0, 1} and t ∈ {0, . . . , τ − 1} and some  > 0.
We make assumptions C.1-C.4 throughout the manuscript. Denote the survival and
censoring function for T at time t ∈ {1, . . . , τ−1} conditioned on study arm a and baseline
variables w by
S(t, a, w) = P (T > t | A = a,W = w), G(t, a, w) = P (C ≥ t | A = a,W = w).
Under assumptions C.1-C.4, we have T⊥⊥C | A,W and therefore S(t, a, w) and G(t, a, w)
have the following product formula representations:
S(t, a, w) =
t∏
m=1
{1− h(m, a,w)}, G(t, a, w) =
t−1∏
m=0
{1− gR(m, a,w)}. (3)
The potential outcome survival function Sc(t, a, z) can be equivalently represented in terms
of the observed data distribution as S(t, a, z) = E{S(t, a,W ) | Z = z}. It follows from (2)
that the causal parameter θc(z) is equal to the following observed-data blip function:
θ(z) =
τ−1∑
t=1
E
{
t∏
m=1
{1− h(m, 1,W )} −
t∏
m=1
{1− h(m, 0,W )} | Z = z
}
. (4)
Thus, the value Vc(d) of a rule d is equal to V (d) = E{d(Z)θ(Z)}, and a corresponding
optimal treatment rule is equal to d0(z) = 1{θ0(z) > 0}, where we denote the corresponding
true quantities (i.e., quantities computed w.r.t. P0) as θ0(z), V0(d), and d0(z).
In addition to assumptions C.1-C.4 above, we sometimes make the following margin
assumption, which is common in the classification literature for plug-in estimators:
C.5 (Margin assumption). There exists a constant λ ≥ 0 such that P0(0 < θ0(Z) ≤ t) . tλ
for all t > 0.
The case λ = 0 is trivial and implies no assumption, whereas λ = ∞ corresponds to
the strongest assumption since it implies that θ0(Z) is bounded away from zero. This
assumption characterizes the behavior of the decision function in the boundary, and has
been shown crucial to establish the convergence of certain classifiers (e.g., Audibert et al.,
2007; Luedtke and Chambaz, 2017).
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4 Plug-in Estimation of the Blip Function and the Optimal
Rule
In this section we discuss various estimators for θ0(z), which can be mapped to a plug-in
estimators through d0(z) = 1{θ0(z) > 0}. Our general strategy relies on the concept of
censoring unbiased transformation, given in Definition 1 below. This concept was first
introduced by Fan and Gijbels (1994) and is further discussed in Rubin and van der Laan
(2007), among others.
Definition 1 (Unbiased transformation). D : O → R is referred to as an unbiased trans-
formation for θ0(z) if E0 {D(O) | Z = z} = θ0(z).
The above definition motivates the construction of estimators of θ0(z) by regressing the
transformation D(O) on the covariates Z. A common complication in this step is that most
unbiased transformations typically depend on unknown nuisance parameters which must
be estimated prior to carrying out the analysis. In this work, we focus on the doubly robust
censoring unbiased transformation Dη defined in Lemma 1 below. In addition to being a
doubly robust unbiased transformation for θ0(z) (i.e., providing robustness to inconsistent
estimation of one out of two nuisance parameters), Dη is an efficient estimating function in
the non-parametric model in the sense that it may be used to construct efficient estimators
of the marginal treatment effect θc,m (see e.g., Dı´az et al., 2015).
Lemma 1 (Doubly robust censoring unbiased transformation). Define
Dη(O) =
τ−1∑
m=1
[
ImZ(m,A,W ) {Lm − h(m,A,W )}+ S(m, 1,W )− S(m, 0,W )
]
, (5)
where Z(m,A,W ) = Z1(m,A,W )− Z0(m,A,W ), and
Za(m,A,W ) = −
τ−1∑
t=m
1{A = a}
gA(a,W )G(m, a,W )
S(t, a,W )
S(m, a,W )
. (6)
Assume η = (h, gA, gR) is such that h = h0 or (gA, gR) = (gA,0, gR,0). Then Dη is an
unbiased transformation for θ0(z), that is, E0 {Dη(O) | Z = z} = θ0(z) .
As a consequence of the previous lemma, the expected value of the quadratic loss
function Lη(O; θ) = {Dη(O) − θ(Z)}2 is minimized at θ0 if η = (h, g) is such that either
h = h0 or g = g0.
For a loss function Lη, we denote its expected value as R0,η(θ) = E0{Lη(O; θ)} and refer
to it as the risk. We now discuss the construction of super learning ensembles of candidate
estimators for θ that target minimization of the quadratic risk. Consider a collection of
estimation algorithms for estimating θ0, hereby called a library, L = {θˆj : j = 1, . . . , J}.
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For an estimator ηˆ of η0, in light of the discussion of the previous section, this library may be
constructed by considering any predictive algorithm that minimizes the quadratic risk for
prediction of the doubly robust unbiased transformation Dηˆ(O). The literature in machine
and statistical learning provides us with a wealth of algorithms that may be used in this
step. Examples include algorithms based on regression trees (e.g., random forests, Bayesian
regression trees), algorithms based on smoothing (e.g., generalized additive models, local
polynomial regression, multivariate adaptive regression splines), and others (e.g., support
vector machines, neural networks).
Consider the following cross-validation set up. Let V1, . . . ,VK denote a random parti-
tion of the index set {1, . . . , n} into K validation sets of approximately the same size. That
is, Vk ⊂ {1, . . . , n};
⋃K
k=1 Vk = {1, . . . , n}; and Vk ∩ Vk′ = ∅. In addition, for each k, the
associated training sample is Tk = {1, . . . , n} \ Vk. Denote ηˆk the estimator of η0 trained
only using data in Tk. Likewise, denote by θˆj,k the estimator of θ0 obtained by training the
j-th predictive algorithm in L using only data in the sample Tk (e.g., regressing Dηˆk(Oi)
on Vi for i ∈ Tk). We use k(i) to denote the index of the validation set that contains
observation i. The cross-validated prediction risk of θˆj is defined as
Rˆηˆ(θˆj) =
1
K
n∑
i=1
1
|Vk(i)|
Lηˆk(i)(Oi, θˆj,k(i)).
In this paper we consider an ensemble learner given by a convex combination
θˆα(z) =
J∑
j=1
αj θˆj(z), αj ≥ 0,
J∑
j=1
αj = 1.
The weights αj are chosen to minimize the cross-validated risk of the above combination,
that is:
αˆ = arg min
α
n∑
i=1
1
|Vk(i)|
Dηˆk(i)(Oi)−
J∑
j=1
αj θˆj,k(i)(Vi)

2
subject to αj ≥ 0,
J∑
j=1
αj = 1.
The above expression is a weighted ordinary least squares problem with constraints on
the coefficients, and may therefore be solved using standard off-the-shelf regression or
optimization software. We denote this super learner with θˆsl = θˆαˆ.
The optimality of general cross-validation selection procedures is discussed in van der
Laan & S. Dudoit & A.W. van der Vaart (2006); van der Vaart et al. (2006). Optimality
here is defined in terms of asymptotic equivalence with the oracle risk, which we define as
the risk computed when (i) one of the components of the nuisance parameter η0 is known,
and (ii) a validation sample of infinite size is available to assess the performance of the
estimator. Specifically,
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Definition 2 (Oracle risk and oracle selector). Let η1 = (g1, h1), where either g1 = g0, or
h1 = h0. The oracle risk of a candidate θˆα is defined as
R˜η1(θˆα) =
1
K
K∑
k=1
∫ {
Dη1(o)− θˆα,k(z)
}2
dP0(o).
The oracle selector is equal to
α˜ = arg min
α
R˜η1(θˆα) subject to αj ≥ 0,
J∑
j=1
αj = 1,
and the corresponding oracle blip function is denoted with θˆor = θˆα˜.
The risk R˜η1(θ0) =
∫
Lη1(o; θ0)dP0(o) is the optimal risk (with respect to the loss
function Lη1 , which in light of Lemma 1 is a valid loss function) achieved by the true θ0.
The following theorem provides a bound on the excess risk of the estimator θˆsl and the
excess risk of θˆor. The excess risk for a selector αˆ is defined as the difference between the
oracle risk of the selector αˆ and the optimal risk, i.e.,
E2(θˆαˆ) = E{R˜η1(θˆαˆ)− R˜η1(θ0)} = EP0(θˆα − θ0)2,
where we remind the reader that the expectation is taken over draws of O1, . . . , On. We
denote this excess risk as E2(θˆαˆ), below we refer to its square root as E(θˆαˆ). We show that
the above excess risk is bounded by two terms: one depending on the excess risk of the
oracle selector E(θˆor), and another one depending on doubly robust terms associated to
estimation of η0.
Theorem 1 (Oracle inequality for the super learner of the blip function). Let η1 = (g1, h1)
denote the element-wise L2(P0) limit of ηˆ as n → ∞, and assume that either g1 = g0 or
h1 = h0. Define
B1(ηˆ, η0) = E||(gˆ − g0)(hˆ− h0)||
B2(ηˆ, η0) = E
{
1(g1 = g0)||gˆ − g0||+ 1(h1 = h0)||hˆ− h0||
}2
.
Then, for δ > 0
E(θˆsl) ≤ (1 + 2δ)1/2 E(θˆor) + C1 {(1 + log n)/n}1/2 +
C2B1(ηˆ, η0) + C3 (log n/n)
1/4 {B2(ηˆ, η0)}1/2 (7)
for constants C1, C2, and C3.
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Note that the terms B1(ηˆ, η0) and B2(ηˆ, η0) converge to zero if either gˆ or hˆ converge
to g0 or h0, respectively, in L2(P0) norm. This implies that the doubly robust property of
Dη(o) is transferred to the oracle inequality. To the best of our knowledge this result had
not been previously shown in the literature.
The super learner θˆsl may be used to construct a plug-in estimator of the optimal rule
as dˆ(z) = 1{θˆsl(z) > 0}. The following remark discusses the convergence rates of the value
of the selected rule V0(dˆ) to the value of the oracle rule V0(d˜).
Remark 1 (Convergence rates to the oracle value). Assume
B1(ηˆ, η0) = O
(
(log n/n)1/2
)
, B2(ηˆ, η0) = O
(
(log n/n)1/2
)
.
Lemma 5.3 of Audibert et al. (2007), along with Jensen’s inequality, show that under as-
sumption C.5, we have
E{V0(d˜)− V0(dˆ)} . {E2(θˆsl)− E2(θˆor)}(1+λ)/(2+λ),
where d˜(z) = 1{θˆor(z) > 0} is the oracle rule. This yields the following convergence rate:
E{V0(d˜)− V0(dˆ)} = O
(
(log n/n)(1+λ)/(2+λ)
)
.
An example of a case yielding the above rate is a randomized study (gA,0(w) = q ∈ (0, 1))
with no censoring (P0(∆ = 1) = 1.) In this case, a logistic regression fit of A on W con-
taining at least an intercept would yield an estimator satisfying ||gˆA − gA,0||2 = OP (n−1).
Plugging in the true value gR,0(t, a, w) = 0 for gˆR(t, a, w), and assuming hˆ is inconsis-
tently estimated yields B1(ηˆ, η0) = O(n
−1/2) and B2(ηˆ, η0) = O(n−1/2). Under no margin
assumption (λ = 0) we get a convergence rate of (log n/n)1/2. Under a strong margin
assumption in which θ0(Z) is bounded away from zero (λ =∞) we get a rate of log n/n.
The above convergence result establishes the convergence of the value of our estimator
dˆ to the value of the oracle d˜. This is different from the typical result in the classification
literature, which establishes convergence to the optimal value V0(d0). The latter result often
involves fast learning rates (sometimes faster than n−1) and requires restricting the class
of blip functions considered to Ho¨lder (Audibert et al., 2007) or Donsker (Luedtke and
Chambaz, 2017) classes, a restriction we do not impose.
5 Super Learner Ensembles for the Optimal Rule from a
Classification Perspective
5.1 Estimators Using the 0-1 Loss Function
In this section we discuss a classification approach that aims at directly estimating the
optimal rule d0(z). Our approach here differs from the previous section in that we do not
10
attempt to estimate the blip function. Instead, we introduce the concept of a decision
function, defined as f : Z→ R, and which yields a treatment rule df (z) = 1{f(z) > 0}. In
a slight abuse of notation we use V (f) to refer to the value of the rule df . Any function
f0 such that sign{f0(z)θ0(z)} = 1 has optimal value V0(d0). This provides intuition on
the benefits of directly optimizing the value of the loss function instead of the risk of the
blip function: an inconsistent estimator of the blip function may provide an optimal rule,
as long as its sign is correct. For a given rule df , in light of Lemma 1, we have that
V0(f) = E0{df (Z)Dη(O)} if η is such that either h = h0, or g = g0. Thus, a decision
function that optimizes the value of the rule df may be found as
f0 ∈ arg max
f
∫
df (z)Dη(o)dP0(o).
For a binary value b ∈ {0, 1} and any X we have bX = 1{X > 0}|X|−|X|1 [1{X > 0} 6= b].
Thus, the optimization problem may be recast as f0 ∈ F0, where F0 = arg minf
∫
Lη(o; f)dP0
and
Lη(o; f) = |Dη(o)|1 [1{Dη(o) > 0} 6= df (z)] . (8)
Expression (8) is a weighted classification loss function in which we aim to classify the
binary outcome 1{Dη(O) > 0} based on data Z, using the 0-1 loss function with weights
given by |Dη(O)|. The objective is to classify an individual who benefits from treatment
arm A = 1 (i.e., an individual with Dη(O) > 0) as requiring treatment (i.e., df (Z) = 1),
while penalizing for the loss |Dη(O)| incurred if the individual were misclassified.
In what follows we consider a library of algorithms for estimation of the decision function
L = {fˆj(z) : j, . . . , J}. In light of the discussion of the previous sections, the most natural
choice for a decision function is the blip function θˆ(z). However, we do not restrict our
setup to functions with a blip interpretation. In addition to estimators of the blip function
θ0(z), the library may contain other decision functions such as the support vector machines
proposed by Zhao et al. (2015) and the parametric decision functions of Bai et al. (2016).
We construct an ensemble of the decision functions as
fˆα(z) =
J∑
j=1
αj fˆj(z), αj ≥ 0. (9)
In this way, we generate an ensemble optimal rule as dˆα(z) = 1{fˆα(z) > 0}. As in the
previous section, we define the super learner selector as
αˆ ∈ arg min
α
n∑
i=1
1
|Vk(i)|
Lηˆk(i)
(
Oi, fˆα,k(i)
)
subject to αj ≥ 0,
where fˆα,k(i) represents (9) with fˆj(z) replaced by fˆj,k(i)(z): the j-th decision function
estimated using the training sample Tk(i). The super learner of the decision function is
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defined as fˆsl(z) = fˆαˆ(z), and the corresponding optimal rule is defined as dˆsl = 1{fˆsl(z) >
0}.
For η1 = (g1, h1) such that either g1 = g0 or h1 = h0, the oracle risk of the decision
function is defined as
R˜η1(fˆ) =
1
K
K∑
k=1
∫
Lη1(o, fˆk)dP0(o).
The oracle selector of α is thus defined as α˜ ∈ arg minα R˜η1(fˆα), and we denote fˆor = fˆα˜.
The excess risk of an estimator fˆ is equal to
E(fˆ) = E{R˜η1(fˆ)− R˜η1(f0)} = V0(f0)− EV0(fˆ).
In Theorem 2 below, we provide bounds on E(fˆsl) in terms of the excess risk of the
oracle selector E(fˆor) and the bias terms B1(ηˆ, η0) and B2(ηˆ, η0) defined in Theorem 1.
Theorem 2 (Oracle inequality for the super learner of the optimal rule). Assume the
conditions of Theorem 1. In addition, assume that αˆ is computed in a grid of size Mnq
for some M > 0, q > 0. Then,
0 ≤ E(fˆsl) ≤ E(fˆor) + C1(log n/n)1/2 + C2B1(ηˆ, η0).
If condition C.5 holds with λ =∞, then, for δ > 0
0 ≤ E(fˆsl) ≤ (1 + 2δ) E(fˆor) + C1 1 + log n
n
+ C2B1(ηˆ, η0) + C3
√
log n
n
B2(ηˆ, η0).
for constants C1, C2, and C3, where B1 and B2 are defined as in Theorem 1.
Remark 2. Assume B1(ηˆ, η0) converges as in Remark 1. An immediate consequence of
the above result is that under no margin assumption, we have E{V0(dˆor) − V0(dˆsl)} =
O
(
(log n/n)1/2
)
. Under the strong margin assumption C.5 with λ =∞ we have E{V0(dˆor)−
V0(dˆsl)} = O(log n/n). These rates are identical to the rates obtained in Remark 1 for the
plug-in estimator. The question of whether analogous convergence rates may be obtained
for other values of λ under condition C.5 remains an open problem.
In comparison to Theorem 1, Theorem 2 has the additional assumption that the op-
timization of the loss function is carried out in a grid polynomial size in n. Inspection of
the proofs of the theorems in the Supplementary Material reveals the reason for the ad-
ditional assumption: the 0-1 loss function is non-smooth and the Lipschitz condition used
in the proof of Theorem 1 does not apply. As demonstrated in our data application, this
assumption is likely to have little practical consequences, but it is unclear to us whether it
can be removed.
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5.2 Using a Surrogate Loss Function for the 0-1 Loss
It is well known in the statistical learning literature that minimizing (8) is generally difficult
due to the discontinuity and non-convexity of the 0-1 loss. A common approach to mitigate
the issues arising from the discontinuity and non-convexity of the 0-1 loss function is to
use surrogates loss functions, such as the logistic loss φ(x) = log(1 + exp(−x)) or the hinge
loss φ(x) = max(1−x, 0). We have the following result, which teaches us that any decision
function df0(z) based on a decision function f0 ∈ Fφ,0 has the same performance as the
optimal rule d0(z).
Lemma 2. Assume η is such that either h = h0, or g = g0. Define
Fφ,0 = arg min
f
∫
Lφ,η(o; f)dP0(o), (10)
where the surrogate loss Lφ,η is defined as
Lφ,η(o; f) = |Dη(o)|φ
(
f(z) [21{Dη(o) > 0} − 1]
)
.
Then we have Fφ,0 ⊆ F0, where F0 = arg minf
∫
Lη(o; f)dP0.
6 Estimating the Optimal Treatment for Breast Cancer Pa-
tients in our Motivating Application
Different types of human breast cancer tumors have been shown to have heterogeneous
response to treatments (Perou et al., 2000; Sotiriou and Pusztai, 2009). Amplification of
ERBB2 gene and associated overexpression of human epidermal growth factor receptor
(HER2) encoded by this gene occur in 25-30% of breast cancers (Slamon et al., 2001).
HER2-positive breast cancer is an aggressive form of the disease and the prognosis for such
patients is generally poor (Slamon, 1987; Seshadri et al., 1993). The clinical efficacy of
adjuvant trastuzumab, a recombinant monoclonal antibody, in early stage HER2-positive
patients was demonstrated by several large clinical trials (Perez et al., 2011; Romond
et al., 2005). Despite significant improvement in disease-free and overall survival of pa-
tients treated with trastuzumab, about 20-25% patients relapse within 3-5 years (Perez
et al., 2011). In this paper we use data from the North Central Cancer Treatment Group
N9831 study, a phase III randomized clinical trial testing the addition of trastuzumab to
chemotherapy in stage I-III HER2-positive breast cancer.
The total number of patients enrolled in the NCCTG N9831 trial was 3,505. Samples
from 1,390 patients, for whom there was available tissue, were used to quantify mRNA from
a custom codeset of 730 genes created by experts. The available baseline variables may be
thus be categorized in three classes: demographic (e.g, race, age, ethnicity), clinical (e.g.,
tumor grade, tumors size, nodal status, hormone receptor status), and gene expression.
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Among the 1,390 patients, 483 received chemotherapy alone (control arm) and 907 patients
received chemotherapy plus trastuzumab (treatment arm).
The clinical challenge is to identify genetic and demographic profiles for patients with
HER2-positive breast cancer who are unlikely to benefit from adjuvant trastuzumab.
In order to estimate and assess the performance of the estimated rule using different
datasets, we split our data into training and validation datasets, of sizes 1000 and 390,
respectively.
6.1 Estimators of h and gR
According to our theoretical results, the optimality of the estimated treatment rules hinges
upon consistent estimation of at least one of the nuisance parameters h and gR. As a result,
it is crucial to employ flexible methods capable of unveiling complex patterns which are
not visible to the human eye. As demonstrated below in Section 6.3, simple parsimonious
models such as the Cox proportional hazards or logistic regression fail to detect these
complex relations in the data.
In order to accurately estimate the nuisance parameters, we use an ensemble learner
known as the super learner for prediction (van der Laan et al., 2007). We train the ensemble
separately using data from each treatment arm, in order to fully account for treatment-
covariate interactions. Like our rule ensembles, super learning predictors build a combi-
nation of candidate predictors that minimize a cross-validated user-supplied risk function.
Since gR and h are conditional probabilities, we focus on logistic regression ensembles and
the negative log-likelihood loss function, using the R implementation in the SuperLearner
package (Polley et al., 2016). The candidate estimators included in the ensembles are listed
in Table 1, along with the coefficients of each predictor in the ensemble, when trained in
the complete dataset using 5-fold cross-validation.
RF XGB MLP GLM MARS LASSO
gˆR
A = 1 0.100 0.056 0.000 0.000 0.312 0.532
A = 0 0.000 0.301 0.000 0.000 0.294 0.405
hˆ
A = 1 0.023 0.050 0.000 0.000 0.237 0.691
A = 0 0.154 0.086 0.098 0.060 0.123 0.480
Table 1: Coefficients of the super learner ensemble for estimation of gR and h. RF is
random forests, XGB is extreme gradient boosting, MLP is multilayer perceptron, GLM
is logistic regression, MARS is multivariate adaptive splines, and LASSO is L1 regularized
logistic regression.
For random forests, extreme gradient boosting, and multilayer perceptron, the tuning
parameters are tuned using data splitting with the aid of the R caret package (Kuhn et al.,
2016). To avoid p > n, logistic regression and multivariate adaptive splies are estimated
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with a variable screening algorithm which computes univariate t-statistics and keeps only
the 50 variables with a larger value.
6.2 Candidate Estimators for the Optimal Treatment Rule
According to our discussion in Sections 4 and 5, there are at least three types of esti-
mators for the optimal rule d0. The first type is a simple substitution estimator, ob-
tained through inspection of equation (4), which consists in regressing the blip function
Bˆ(W ) =
∑τ−1
t=1 {Sˆ(t, 1,W ) − Sˆ(t, 0,W )} on Z, where Sˆ is the estimator of the survival
function corresponding to the estimator hˆ described in Section 6.1. The second type is
obtained through regression of the unbiased transformation Dηˆ(O) on Z. The third type
of estimation methods is obtained based on equation (8), and is obtained by classifying the
binary outcome 1{Dηˆ(O) > 0} as a function of Z, with weights given by |Dηˆ(O)|. Here,
ηˆ = (gˆR, hˆ), where the components of ηˆ are as described in Section 6.1. Any regression
or supervised classification technique available in the statistical learning literature may be
used as a candidate for solving these problems.
In our application, we focus on the following candidates for estimating d0:
B-Reg Regression of the blip function Bˆ(W ) using super learning with can-
didate learners as described in Table 1.
D-Reg Regression of the doubly robust transformation Dηˆ(O) using super
learning with candidate learners as described in Table 1.
D-Class-RF Weighted classification of 1{Dηˆ(O) > 0} using random forests.
D-Class-XGB Weighted classification of 1{Dηˆ(O) > 0} using extreme gradient
boosting.
D-Class-GLM Weighted classification of 1{Dηˆ(O) > 0} using logistic regression.
According to our discussion in Sections 4 and 5, we also train four super learning
ensembles of the above candidate estimators, using different loss functions:
SL-Reg Regression ensemble minimizing the expected quadratic loss
function.
SL-Class-01 Classification ensemble minimizing the expected 0-1 loss function.
SL-Class-Hinge Classification ensemble with surrogate hinge loss function.
SL-Class-Log Classification ensemble with surrogate log loss function.
The coefficients of each candidate estimator in each ensemble are presented in Table 2.
These coefficients were computed using the Subplex (Rowan, 1990) routine implemented
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in the NLopt nonlinear-optimization R package. For improved robustness, the 0-1 loss was
optimized using 1000 different random starting values.
SL-Reg SL-Class-0-1 SL-Class-Hinge SL-Class-Log
D-Class-RF 0.000 0.005 0.000 0.000
D-Class-XGB 0.792 0.001 0.945 0.869
D-Class-GLM 0.000 0.031 0.000 0.000
D-Reg 0.007 0.017 0.001 0.006
B-Reg 0.201 0.947 0.054 0.125
Table 2: Coefficients of each candidate in each ensemble (standardized to sum one). The
rows represent the candidates, the columns the ensemble.
6.3 Assessing the Performance of The Estimated Treatment Rule
Once each rule is estimated using only data in the training dataset, its value V (dˆ) is
estimated on the validation dataset. To that effect, we use the targeted minimum loss
based estimator of the restricted mean survival time proposed by Dı´az et al. (2015) (See
also Moore and van der Laan, 2011).
Figure 1 presents the estimated restricted mean survival time obtained with each esti-
mated rule, along with 95% confidence intervals. For comparison, we also present the value
of two static rules of interest: never treat and always treat. As is clear from the figure,
the best algorithm in our application is regression of the blip function. All super learning
ensembles yield a similar value, demonstrating the oracle property of the super learner.
Treating patients according to the optimal rule yields a restricted mean survival of 157.1
(s.d. 3.1) months. In comparison with the always treat rule, which yields 151.2 (s.d., 3.3)
months, the optimal rule improves mean patient survival by 6 months.
According to Table 2, only the super learning ensemble based on the 0-1 loss assigns a
large weight to the best algorithm. In fact, its restricted mean survival time (see Figure 1)
is identical to that of the optimal rule. The other ensembles assign more weight to the
second best algorithm, weighted classification using extreme gradient boosting, and have
slightly smaller restricted mean survival time. This is in agreement with our theoretical
findings that the best performance is obtained using the 0-1 loss function.
It is also worth noting that three of the estimated rules (weighted classification using
random forests and logistic regression, and regression of the function Dηˆ) yield a restricted
mean survival time smaller or equal than the restricted mean survival time of the static
rule always treat.
Table 3 in the Supplementary Materials shows the p-value for the pair-wise comparisons
of the value of each estimated rule. A few interesting points to note are:
(i) The ensemble using the 0-1 loss function outperforms the other ensembles, the differ-
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Figure 1: Restricted mean survival time estimated in the validation set, for different esti-
mated rules. The bars represent 95% confidence intervals.
ence in values is small but significant at 5% level.
(ii) The value of the optimal rule, which is obtained through regression of the blip function
(see Figure 1), is significantly different from all other rules, except the ensemble using
the 0-1 loss function. This illustrates the theoretical property of super-learning stating
that the risk of the ensemble converges to the risk of the best candidate in the library.
(iii) Weighted classification using logistic regression, which is often advocated because it
yields parsimonious rules (e.g., Zhang et al., 2015), has a value significantly lower
than the static rule always treat.
In our application, we have decided to use data splitting to train and assess the per-
formance of the estimated rules. Though correct, this approach may be unnecessary, since
the value of the rule may be assessed using the training dataset, under certain conditions
derived by Luedtke et al. (2016).
7 Discussion
We present two methods for constructing an ensemble individualized treatment rule. The
methods are based on a plug-in estimator optimizing the prediction error of the blip func-
tion, and a weighted classification approach which directly estimates the decision function.
Though we found no theoretical differences between the two approaches in terms of their
asymptotic properties, the classification ensemble using the 0-1 loss function yielded better
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treatment rules than the other approaches in our illustrative application. The superior-
ity of the classification approach has been recognized before (e.g., Zhao et al., 2012), and
is a consequence of the fact that it emphasizes optimizing the decision rule rather than
prediction accuracy emphasized by the blip approach.
We consider a survival time measured in a discrete time scale. Most clinical research
studies measure time to event in a discrete scale. In our motivating application, time to
relapse of cancer or death was measured in days. We foresee no technical difficulties in
extending our approach to consider a continuous time to event. This can be achieved by
replacing discrete time hazards by their continuous counterpart, as well as replacing certain
sums over time by the appropriate martingale integrals (see Bai et al., 2016) in the definition
of the censoring unbiased transformation Dη(O). A potential practical limitation is that
the software and literature for data-adaptive machine learning estimation of continuous
time hazards (required for the nuisance parameters) is scarce in comparison to that of
binary classification, which may be used for estimation of discrete time hazards. Among
the few methods that can be used for this problem are (semi)-parametric models such as
Cox regression and accelerated failure time models. Available data adaptive approaches
include survival random forests and regularized Cox regression. If time is measured on
a continuous scale, implementation of our methods requires discretization. The specific
choice of the discretization intervals may be guided by what is clinically relevant. For
example, in cancer research, the clinically relevant scale would typically be a week or a
month. In the absence of clinical criteria to guide the choice of discretization level, a
concern is that too coarse of a discretization may lead to relevant information loss. A
question for future research is how to optimally set the level of discretization in order to
trade off information loss versus estimator precision. Another area for future research is
to consider discretization levels that get finer with sample size.
We present doubly robust oracle inequalities and convergence rates assuming (i) an
exposure of interest that occurs at baseline, and (ii) censoring which is confounded with
the time to event only by baseline variables. We conjecture that our general results apply
to the more general case of a dynamic treatment regime with a time-varying treatment and
time-varying confounders. Such results will be the subject of future research.
In our definition of oracle risk and oracle selector we have used a nuisance parameter
η1 = (g1, h1) satisfying either h1 = h0, or g1 = g0. Therefore these oracle quantities change
depending on which of the two nuisance parameters is correctly specified. According to
efficient estimation theory in semi-parametric models, we expect the case η1 = η0 to yield
oracle quantities with minimal variability. In the single misspecification case in which
h1 = h0 or g1 = g0 but not both, it is unclear to us whether misspecification of one of the
models yields better results than the other. Lastly, our setup includes as particular case
the inverse probability weighted loss function, which may be obtained by using a constant
estimator hˆ(t, a, w) = 1, as well as the g-computation loss function, which is obtained by
using gˆA(a,w) = 1 and gˆR(t, a, w) = 0.
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8 Supplementary Material
8.1 Motivating application
Table 3: P-values of pair-wise comparisons of the value of each rule estimated in the
validation data.
SL-Class-Log 0.026
SL-Class-Hinge 0.026 0.159
SL-Reg 0.025 0.160 0.443
D-Class-RF 0.001 0.001 0.001 0.001
D-Class-XGB 0.001 0.009 0.007 0.007 0.003
D-Class-GLM 0.001 0.001 0.001 0.001 0.011 0.001
D-Reg 0.001 0.004 0.002 0.002 0.158 0.021 0.056
B-Reg 0.120 0.025 0.023 0.023 0.001 0.001 0.001 0.001
Always-Treat 0.001 0.001 0.001 0.001 0.003 0.011 0.158 0.001
Never-Treat 0.001 0.001 0.001 0.001 0.001 0.001 0.036 0.002 0.001 0.001
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8.2 Proofs of Theorems and Lemmas
8.2.1 Lemma 1
Proof For simplicity, consider the treatment-time-specific function
Dm,a,η(O) = −
m∑
t=1
1{A = a}It
gA(a,W )G(t, a,W )
S(m, a,W )
S(t, a,W )
{Lt − h(t, a,W )}+ S(m, a,W ),
and note that Dη =
∑τ−1
m=1(Dm,1,η −Dm,0,η). For a function f(t, a, w) we denote Pf(t) =∫
f(t, a, w)dP (w). Conditioning first on W in the above display yields
E0{Dm,a,η0 | Z} = E0
{
m∏
t=1
{1− h0(t)} | Z
}
.
Thus, we have
E0(Dm,a,η | Z)− E0
{
m∏
t=1
{1− h0(t)} | Z
}
=E0
[
m∑
t=1
−S(m)
S(t)
gA,0
gA
G0(t)
G(t)
S0(t){h0(t)− h(t)}+
m∏
t=1
{1− h(t)} −
m∏
t=1
{1− h0(t)}
∣∣∣∣Z
]
=
m∑
t=1
E0
[
−S(m)
S(t)
gA,0
gA
G0(t)
G(t)
S0(t− 1){h0(t)− h(t)}+ S0(t− 1){h0(t)− h(t)}S(m)
S(t)
∣∣∣∣Z]
=
m∑
t=1
E0
[
−S(m)
S(t)
S0(t− 1){h0(t)− h(t)}
{
gA,0
gA
G0(t)
G(t)
− 1
} ∣∣∣∣Z]
=
m∑
t=1
E0
[
−S(m)
S(t)
S0(t− 1){h0(t)− h(t)}
{
gA,0
gAG(t)
{G0(t)−G(t)}+ 1
gA
(gA,0 − gA)
} ∣∣∣∣Z]
=
m∑
t=1
E0
[
−S(m)
S(t)
S0(t− 1){h0(t)− h(t)}
{
gA,0
gAG(t)
t−1∑
k=0
G0(k){gR,0(k)− gR(k)} G(t)
G(k + 1)
+
1
gA
(gA,0 − gA)
} ∣∣∣∣Z]
Plugging in g = g0 or h = h0 yields the result.
8.2.2 Theorem 1
Proof We start by assuming the minimization of the risk in the definition of αˆ and α˜
is carried out in a grid Bn ⊂ B = {α ∈ RJ : αj ≥ 0,
∑J
j=1 αj = 1} of polynomial size
23
in n (that is |Bn| . nq) for some 1 ≤ q < ∞, but do away with this assumption at the
end of the proof. Let βˆ ad β˜ denote the cross-validated and oracle selectors when the
risk minimization is performed in Bn rather than B. We use Pn,k to denote the empirical
distribution corresponding to the validation set Vk, as well as EK(X) = K−1
∑K
k=1Xk to
denote an average across validation splits. We denote PL(θ) =
∫
L(o; θ)dP (o). Let
η? =

(g0, hˆk) if g1 = g0 and h1 6= h0
(gˆk, h0) if g1 6= g0 and h1 = h0
(g0, h0) if g1 = g0 and h1 = h0
Define the centered loss function
L0η(O; θ) = Lη(O; θ)− Lη1(O; θ0).
In this proof we denote with R the corresponding centered risks, i.e., denote
Rˆηˆ(θˆ) =
1
K
K∑
k=1
1
|Vk|
∑
i∈Vk
L0ηˆk
(
Oi; θˆk
)
R˜ηˆ(θˆ) =
1
K
K∑
k=1
∫
L0ηˆk(o; θˆk)dP0(o)
the corresponding cross-validated and oracle risks. For notational convenience we denote
R(β) = R(θˆβ). Note that R˜η?(β) = E(θˆβ). For δ > 0 we have
0 ≤ R˜η?(βˆ)
≤ R˜η?(βˆ) + (1 + δ){Rˆηˆ(β˜)− Rˆηˆ(βˆ)}
= (1 + 2δ)R˜η?(β˜)
− (1 + δ){Rˆη?(βˆ)− R˜η?(βˆ)} − δR˜η?(βˆ) (11)
+ (1 + δ){Rˆη?(β˜)− R˜η?(β˜)} − δR˜η?(β˜) (12)
+ (1 + δ){Rˆηˆ(β˜)− Rˆη?(β˜)} (13)
− (1 + δ){Rˆηˆ(βˆ)− Rˆη?(βˆ)}
where the second inequality is a consequence of the definition of βˆ as the minimizer of
Rˆηˆ(β), and the last equality is the result of adding and subtracting some terms. Denote
(11) with T , (12) with H, and (13) with Q(α˜).
Note that the assumptions of the theorem imply that P0{|Dη?(O)| ≤M} = 1 for some
constant M . This, together with Lemma 5 below, allow the application of Lemma 3 in
van der Laan and Dudoit (2003) (see also pages 143-145 of Dudoit and van der Laan, 2005)
to show that
E(T +H) . 1 + log n
n
.
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It remains to analyze Q(βˆ) and Q(β˜). First, we write Qβ = Q1(β) +Q2(β), where
Q1(β) = (1 + δ)EKP0(L
0
ηˆk
− L0η?)(θβ,k)
Q2(β) = (1 + δ)EK(Pn,k − P0)(L0ηˆk − L0η?)(θβ,k)
For Q1(β), note that Rη?(β) = EKP0(θ0 − θβ,k)2. This yields, for β ∈ (βˆ, β˜),
EQ1(β) = (1 + δ)EEKP0(L0ηˆk − L0η?)(θβ,k)
= 2(1 + δ)EEKP0(Dηˆk −Dη?)(θ0 − θβ,k)
= 2(1 + δ){EEKP0(Dηˆk −Dη0)(θ0 − θβ,k)− EEKP0(Dη? −Dη0)(θ0 − θβ,k)}
Conditioning on W first, from the definition of η?, Lemma 1 shows that the second term
in the right hand side is zero. Conditioning on W first along with the proof of Lemma 1
and the Cauchy-Schwartz inequality also yields
EQ1(β) = 2(1 + δ)EEKP0(Dηˆk −Dη0)(θ0 − θβ,k)
=
m∑
t=1
EEKP0(θ0 − θβ,k)
[
−S(m)
S(t)
S0(t− 1){h0(t)− h(t)}{
gA,0
gAG(t)
t−1∑
k=0
G0(k){gR,0(k)− gR(k)} G(t)
G(k + 1)
+
1
gA
(gA,0 − gA)
} ∣∣∣∣W
]
≤ 2(1 + δ) [EEKP0(θ0 − θβ,k)2]1/2 ||E(gˆ − g0)(hˆ− h0)||
.
√
ER˜η?(βˆ)B1(ηˆ, η0)
where the last inequality follows from Lemma 5 in Appendix 8.2.5 and the definition of β˜
as the minimizer of R˜η?(β), and the second to last inequality follows from Cauchy-Schwartz
applied to the norm defined by the inner product < fk, gk >= EEKP0fkgk. For Q2(β),
note that (Pn,k − P0)(Lηˆk − Lη?)(θβ,k) is an empirical processes with index set Bn, where
the latter set is finite. We will apply the following inequality for empirical processes with
finite index set:
Emax
f∈F
|(Pn − P0)f | .
√
log |F|
n
||F ||, (14)
where F is an envelope of F . This result is a direct consequence of Lemma 19.38 of van der
Vaart (1998). Note that the all functions in Fk = {(L0ηˆk − L0η?)(θβ,k) : β ∈ Bn} satisfy
P0(L
0
ηˆk
− L0η?)2(θβ,k) = P0{(Dηˆk −Dη?)2(θ0 − θβ,k)2}
. P0(Dηˆk −Dη?)2
. B2(ηˆ, η1),
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where the second inequality follows from Lemma 5. Thus, the envelope Fk of Fk is bounded
by the same quantity. This, together with (14) shows
EQ2(β) .
√
log n
n
B2(ηˆ, η1).
This proves
0 ≤ ER˜η0(βˆ) . (1 + 2δ)ER˜η0(β˜) +
1 + log n
n
+
√
ER˜η0(βˆ)B1(ηˆ, η1) +
√
log n
n
B2(ηˆ, η1),
which is equivalent to x2 − bx ≤ c for
x =
√
ER˜η0(βˆ)
b = B1(ηˆ, η1)
c = (1 + 2δ)ER˜η0(β˜) +
1 + log n
n
+
√
log n
n
B2(ηˆ, η1).
The quadratic formula x ≤ (b+√b2 + 4c)/2 implies x ≤ b+√c, which yields
0 ≤
√
ER˜η0(βˆ) .
√
(1 + 2δ)ER˜η0(β˜) +
√
1 + log n
n
+B1(ηˆ, η0) +
[
log n
n
]1/4√
B2(ηˆ, η0)
(15)
From our definitions and assumptions, the function f(β) = Rη0(θˆβ) satisfies the Lipschitz
condition
||f(β)− f(α)||∞ . ||β − α||2,
where || · ||∞ denotes the supremum norm and || · ||2 the Euclidean norm. Thus f(βˆ)−f(αˆ)
and f(β˜) − f(α˜) are both bounded by n−q, which allows us to replace (βˆ, β˜) by (αˆ, α˜) in
(15), completing the proof of the theorem.
8.2.3 Theorem 2
Proof
For convenience in the calculations we use the loss function
Lη(o; f) = −Dη(o)df (z) = −1{Dη(o) > 0}Dη(o) + |Dη(o)|1[1{Dη(o) > 0} 6= df ],
which is equivalent to the one used in the Theorem. Let η?, L0η(O; f), Rˆη(β), and R˜η(β)
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be defined as in the proof of Theorem 1. We have
0 ≤ R˜η?(βˆ)
= R˜η?(β˜)
+{R˜ηˆ(β˜)− R˜η?(β˜)}
+{Rˆηˆ(βˆ)− R˜ηˆ(β˜)}
+{R˜ηˆ(βˆ)− Rˆηˆ(βˆ)}
−{R˜ηˆ(βˆ)− R˜η?(βˆ)}.
Define
T (β) = (Rˆηˆ − R˜ηˆ)(β)
Q(β) = (R˜ηˆ − R˜η?)(β).
Since, by definition, Rˆηˆ(βˆ) ≤ Rˆηˆ(β˜), we have
0 ≤ R˜η?(βˆ) + T (β˜)− T (βˆ) +Q(β˜)−Q(βˆ).
van der Laan and Dudoit (2003), page 26, show that
ET (β˜)− ET (βˆ) . (log n/n)1/2.
In the proof of Theorem 2, we show that
EQ(β˜)− EQ(βˆ) . B1(ηˆ, η0),
completing the proof of first claim of the theorem.
Assume now condition C.5 holds with α =∞ such that infz∈Z |θ0(z)| > 0 The proof in
this case has the same steps as the proof of Theorem 1 and we will only provide a sketch.
The conditions of the Theorem allow application of Lemma 4 below to obtain
E(T +H) . 1 + log n
n
.
For Q1(α) and Q2(α) we get
EQ1(α) = (1 + δ)EEKP0(L0ηˆk − L0η?)(fα,k)
= 2(1 + δ)EEKP0(Dηˆk −Dη0)(dfα,k − d0)
=
m∑
t=1
EEKP0(dfα,k − d0)
[
−S(m)
S(t)
S0(t− 1){h0(t)− h(t)}{
gA,0
gAG(t)
t−1∑
k=0
G0(k){gR,0(k)− gR(k)} G(t)
G(k + 1)
+
1
gA
(gA,0 − gA)
} ∣∣∣∣W
]
≤ 2(1 + δ) [EEKP0(θ0 − θβ,k)2]1/2 E||(gˆ − g0)(hˆ− h0)||
. B1(ηˆ, η0).
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For Q2(α), note that (Pn,k − P0)(Lηˆk − Lη?)(fα,k) is an empirical processes with index set
An, where the latter set is the finite set with Mnq points in which αˆ is computed. We will
apply inequality (14). Note that the all functions in Fk = {(L0ηˆk − L0η?)(fα,k) : α ∈ An}
satisfy
P0(L
0
ηˆk
− L0η?)2(θα,k) = P0{(Dηˆk −Dη?)2(dfα,k − d0)2}
. P0(Dηˆk −Dη?)2
. B22(ηˆ, η1),
where the second inequality follows from Lemma 5. Thus, the envelope Fk of Fk is bounded
by the same quantity. This, together with (14) shows
EQ2(α) .
√
log n
n
B2(ηˆ, η1).
This completes the proof.
8.2.4 Lemma 2
Proof This is a direct application of Theorems 1 (part 3) and 2 of Bartlett et al. (2006).
See also Theorem 5 of Luedtke and van der Laan (2016).
8.2.5 Lemmas
Lemma 3. Consider the assumptions of Theorem 1. Let Z = Lη0(O; θ)− Lη0(O; θ0). We
have
Var0(Z) . E0(Z)
Proof First, note that
Z = {θ0(Z)− θ(Z)}{2Dη0(O)− θ(Z)− θ0(Z)}.
In light of Lemma 1 we have
E0(Z) = E0{θ0(Z)− θ(Z)}2.
Note that P0{|2Dη0 − θ(Z)− θ0(Z)| ≤ 4 max(M,C1)} = 1. Thus
Var0(Z) ≤ E0(Z2)
= E{θ0(Z)− θ(Z)}2{2Dη0(O)− θ(Z)− θ0(Z)}2
≤ 16 max(M2, C21 )E0(Z),
which completes the proof of the lemma.
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Lemma 4. Consider the assumptions of Theorem 2. Let
Lφ,η(o, f) = Dη(o)df (z),
Let Z = Lη1(O; θ)− Lη1(O; θ0). We have
Var0(Z) . E0(Z)
Proof We have
E0[Z
2] = E0|d0(Z)− df (Z)|2D2η1
≤ CE01{d0(Z) 6= df (Z)}
≤ CE0 |θ0(Z)|
infz |θ0(Z)|1{d0(Z) 6= df (Z)}
≤ C2E0|θ0(Z)|1{d0(Z) 6= df (Z)}
= C2E0(Z).
Lemma 5. For each ηˆ = (gˆ, hˆ)→ η1 = (g1, h1) such that either g1 = g0 or h1 = h0 define
η? =

(g0, hˆ) if g1 = g0 and h1 6= h0
(gˆ, h0) if g1 6= g0 and h1 = h0
(g0, h0) if g1 = g0 and h1 = h0.
We have
P0(Dηˆ −Dη?)2 . B2(ηˆ, η1),
with B2 defined in Theorem 1.
Proof First let g1 = g0 and h1 6= h0. Then η? = (g0, hˆ) and straightforward algebra
shows
P0(Dηˆ −Dη?)2 . ||gˆ − g1||2
Analogously, for g1 6= g0 and h1 = h0 we have
P0(Dηˆ −Dη?)2 . ||hˆ− h1||2.
Now, for g1 = g0 and h1 = h0 we get
P0(Dηˆ −Dη?)2 . {||hˆ− h1||+ ||gˆ − g1||}2.
Putting these results together proves the lemma.
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Lemma 6. For two sequences a1, . . . , am and b1, . . . , bm we have
m∏
t=1
(1− at)−
m∏
t=1
(1− bt) =
m∑
t=1
{
t−1∏
k=1
(1− ak)(bt − at)
m∏
k=t+1
(1− bk)
}
.
Proof Replace (bt − at) by (1 − at) − (1 − bt) in the right hand side and expand the
sum to notice it is a telescoping sum.
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